News

S’pore’s billion-dollar biotech firm: Life sciences scholar leads start-up to list in HK
Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...
Chinese listing spree sparks revival hopes in Hong Kong stocks
A wave of listings by Chinese companies is expected to reinvigorate trading activity in Hong Kong, with optimism growing that ...
ANTARA News5h
TWSE and GrandTech Cloud Host F2SU Asia IPO Forum to Showcase Taiwan's Capital Market Strength
Taiwan Stock Exchange (the TWSE), in partnership with GrandTech Cloud Services Inc., co-hosted the "F2SU Asia IPO Synergy" ...
UBS upbeat on China stocks, citing tariff pause with US and potential Beijing stimulus
Swiss bank also cites low valuations for Chinese equities as investors diversify away from US assets UBS Group is optimistic ...
Invidior: Drug maker ditches London for US
The London Stock Exchange suffered another blow on Monday after drug maker Invidior said it intends to abandon its London ...
Drugmaker Indivior drops London listing to cut costs
(Reuters) -Pharma firm Indivior said on Monday it would cancel its secondary listing on the London Stock Exchange, effective July 25, maintaining its primary listing on the Nasdaq to reduce costs and ...
Opinion
New World’s Bond Coupon Delay Raises Three Questions
Hong Kong-based New World Development Co.’s decision to defer interest payments on four perpetual notes took investors by surprise. While this is by no means an action of default — a perpetual ...